Phospho-GSK-3α/β (Ser21/9) Antibody [N3H2]

N. catalogo F0496

Stampa

Descrizione biologica

Specificità L'anticorpo Phospho-GSK-3α/β (Ser21/9) [N3H2] rileva i livelli endogeni della proteina GSK-3α totale solo quando è fosforilata in Ser21, e anche i livelli endogeni della proteina GSK-3β totale solo quando è fosforilata in Ser9.
Contesto Phospho-GSK-3α/β (Ser21/9) rappresenta la forma inattivata della glicogeno sintasi chinasi-3 (GSK-3), una famiglia di proteine chinasi serina/treonina con due isoforme, GSK-3α e GSK-3β, espresse ubiquitariamente e originariamente identificate per il loro ruolo nella regolazione del metabolismo del glicogeno. GSK-3 possiede una regione N-terminale contenente i residui di serina regolatori chiave Ser21 (in GSK-3α) e Ser9 (in GSK-3β) che, quando fosforilati, agiscono come un pseudo-substrato per inibire competitivamente l'accesso alla tasca di legame del substrato innescata nel dominio catalitico; l'attivazione si basa inoltre sulla fosforilazione di Tyr279 (GSK-3α) o Tyr216 (GSK-3β) nell'ansa di attivazione. GSK-3 mantiene un'attività costitutiva nelle cellule non stimolate ma viene principalmente inattivata attraverso la fosforilazione di Ser21/9 da chinasi come Akt (attivata tramite la via PI3K in risposta a fattori di crescita, insulina o stressori), che blocca l'aggancio del substrato e arresta la fosforilazione di oltre 100 bersagli che richiedono un fosfo-residuo di innesco quattro residui C-terminali al sito. Questa inattivazione promuove la sintesi del glicogeno, la sopravvivenza cellulare, la proliferazione e processi come la segnalazione Wnt prevenendo la degradazione della β-catenina mediata da GSK-3, mentre contrasta l'apoptosi, l'iperfosforilazione della tau (rilevante per l'Alzheimer) e il turnover della ciclina D1. La defosforilazione in Ser21/9 da parte di fosfatasi come PP1, PP2A o PP2B riattiva GSK-3, causando neurodegenerazione, cancro e disturbi metabolici quando è deregolata.

Informazioni sullutilizzo

Applicazione WB, IP Diluizione
WB IP
1:1000 1:50
Reattività Human, Mouse, Rat, Monkey
Fonte Rabbit Monoclonal Antibody MW 51 kDa, 46 kDa
Tampone di conservazione PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Conservazione
(Dalla data di ricevimento)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Riferimenti

  • https://pubmed.ncbi.nlm.nih.gov/11035810/
  • https://pubmed.ncbi.nlm.nih.gov/25435019/

Dati di applicazione

WB

Validato da Selleck

  • F0496-wb
    Lane 1: COS-7 (λ phosphatase treated), Lane 2: COS-7 (PDGF, 100ng/mL, 5 min)